Matsumoto, Y · Nihon rinsho. Japanese journal of clinical medicine · 1999
This paper discusses fibromyalgia syndrome (FMS), a condition characterized by widespread pain, fatigue, sleep problems, and mood changes without visible inflammation or damage on tests. The author explains that while fibromyalgia is recognized as real, some doctors still debate whether it is truly distinct from other conditions. Many people with ME/CFS also meet the criteria for fibromyalgia, but there are some differences between the two conditions—such as signs of viral triggers and low blood chemical levels found in ME/CFS but not usually in fibromyalgia.
This paper is important because it directly addresses the relationship between ME/CFS and fibromyalgia—two conditions that frequently co-occur and are sometimes confused. By identifying biochemical differences between the conditions (such as serum acylcarnitine abnormalities and viral triggers in CFS but not FMS), the authors support the view that ME/CFS and FMS, while overlapping, may be distinct biological entities. This distinction is crucial for developing targeted treatments and improving diagnostic accuracy.
This editorial does not provide new experimental data and therefore does not definitively prove that FMS and CFS are distinct disorders. The assertion about differences in viral triggers and acylcarnitine levels is based on existing literature, not original research presented here. The paper also does not establish what causes either condition or prove that current diagnostic criteria reliably separate FMS from CFS in clinical practice.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →